Home › Companies › HAEMONETICS CORP. › 2023-2024
Compiled from SEC Form N-PX filings and HAEMONETICS CORP.’s Form 8-K, filed 2023-08-07 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore HAEMONETICS CORP. in the interactive database Compare manager voting policies
These tallies are HAEMONETICS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2023-08-07 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Christopher A. Simon | 46,433,691 | -- | -- | 328,714 | 1,685,092 | Majority: yes |
| Elect Director: Robert E. Abernathy | 45,088,242 | -- | -- | 1,674,163 | 1,685,092 | Majority: yes |
| Elect Director: Michael J. Coyle | 46,424,781 | -- | -- | 337,624 | 1,685,092 | Majority: yes |
| Elect Director: Charles J. Dockendorff | 45,030,197 | -- | -- | 1,732,208 | 1,685,092 | Majority: yes |
| Elect Director: Lloyd E. Johnson | 42,123,209 | -- | -- | 4,639,196 | 1,685,092 | Majority: yes |
| Elect Director: Mark W. Kroll | 46,097,712 | -- | -- | 664,693 | 1,685,092 | Majority: yes |
| Elect Director: Claire Pomeroy | 46,378,877 | -- | -- | 383,528 | 1,685,092 | Majority: yes |
| Elect Director: Ellen M. Zane | 39,666,573 | -- | -- | 7,095,832 | 1,685,092 | Majority: yes |
| Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes: | 44,958,577 | 1,776,928 | 26,900 | -- | 1,685,092 | Majority: yes |
| Proposal 4: The shareholders approved a proposal to adopt an amendment and restatement of the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan based upon the following votes: | 45,678,506 | 1,058,808 | 25,091 | -- | 1,685,092 | Majority: yes |
| Proposal 5: The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes: | 47,679,417 | 748,049 | 20,031 | -- | -- | Majority: yes |
Source: HAEMONETICS CORP., Form 8-K, filed with the SEC on 2023-08-07 — read the filing on EDGAR.
Each item below shows how the 345 asset managers that disclosed a HAEMONETICS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of HAEMONETICS CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Meeting held 2023-08-04.
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”): 44,958,577 for, 1,776,928 against, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 89% for, 4% against (92% of the company cast a for/against vote).
The 324 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Research Global Investors | 6,687,612 | 0 | 0 | 0 | For |
| Vanguard | 6,341,256 | 0 | 0 | 0 | For |
| Neuberger Berman | 5,741,067 | 613 | 0 | 0 | For |
| BlackRock | 5,191,294 | 6,768 | 0 | 0 | For |
| Fidelity | 4,499,186 | 0 | 0 | 0 | For |
| Capital Group | 4,083,194 | 0 | 0 | 0 | For |
| Wellington | 2,854,967 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| State Street | 1,987,744 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 1,490,795 | 0 | 0 | 0 | For |
| Invesco | 1,302,489 | 0 | 0 | 0 | For |
| Charles Schwab | 1,006,384 | 0 | 0 | 0 | For |
| Janus Henderson | 1,000,000 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 950,724 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| T. Rowe Price | 927,579 | 0 | 0 | 0 | For |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 911,386 | 0 | 0 | 0 | For |
| Royce | 865,531 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 651,781 | 0 | 0 | 0 | For |
| Man Group plc | 0 | 643,770 | 0 | 0 | Against |
| Dimensional | 635,626 | 0 | 0 | 0 | For |
| Bridgewater | 519,150 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| Allspring | 481,062 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 382,805 | 29,974 | 0 | 0 | For |
Showing the 25 largest of 324 asset managers. See all 324 in the interactive database.
Meeting held 2023-08-04.
Combines 3 wordings of this item as funds reported it.
98% fund support · no official result
The 306 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Research Global Investors | 0 | 0 | 0 | 0 | One Year |
| Vanguard | 0 | 0 | 0 | 0 | One Year |
| Neuberger Berman | 0 | 0 | 0 | 0 | 1 Year |
| BlackRock | 0 | 0 | 0 | 0 | One Year |
| Fidelity | 0 | 0 | 0 | 0 | One Year |
| Capital Group | 0 | 0 | 0 | 0 | One Year |
| Wellington | 0 | 0 | 0 | 0 | 1 Year |
| AMCAP FUND | 0 | 0 | 0 | 0 | One Year |
| State Street | 0 | 0 | 0 | 0 | One Year |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | One Year |
| Invesco | 0 | 0 | 0 | 0 | One Year |
| Charles Schwab | 0 | 0 | 0 | 0 | 1 Year |
| Janus Henderson | 0 | 0 | 0 | 0 | One Year |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| Franklin Custodian Funds | 0 | 0 | 0 | 0 | One Year |
| T. Rowe Price | 0 | 0 | 0 | 0 | One Year |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 0 | 0 | 0 | 0 | 1 Year |
| Royce | 0 | 0 | 0 | 0 | One Year |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | One Year |
| Man Group plc | 0 | 0 | 0 | 0 | 1 Year |
| Dimensional | 0 | 0 | 0 | 0 | Three Years |
| Bridgewater | 0 | 0 | 0 | 0 | 1 Year |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | One Year |
| Allspring | 0 | 0 | 0 | 0 | One Year |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0 | 0 | 0 | 0 | One Year |
Showing the 25 largest of 306 asset managers. See all 306 in the interactive database.
Meeting held 2023-08-04.
Combines 7 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Proposal 4: The shareholders approved a proposal to adopt an amendment and restatement of the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan based upon the following votes:”): 45,678,506 for, 1,058,808 against, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 90% for, 2% against (92% of the company cast a for/against vote).
The 115 asset managers below cast 99.7% of the shares they voted on this item FOR (30,805,681 for, 69,251 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,202,371 | 0 | 0 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 380,101 | 0 | 0 | 0 | For |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 283,956 | 0 | 0 | 0 | For |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 203,499 | 0 | 0 | 0 | For |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 115 asset managers. See all 115 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 45,030,197 for, 1,732,208 withheld, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 89% for, 3% withheld (92% of the company cast a for/withheld vote).
The 114 asset managers below cast 100% of the shares they voted on this item FOR (30,550,918 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,202,371 | 0 | 0 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 380,101 | 0 | 0 | 0 | For |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 283,956 | 0 | Abstain |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 203,499 | 0 | 0 | 0 | For |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Christopher A. Simon”): 46,433,691 for, 328,714 withheld, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 92% for, 0.7% withheld (92% of the company cast a for/withheld vote).
The 114 asset managers below cast 100% of the shares they voted on this item FOR (30,908,346 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,202,371 | 0 | 0 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 380,101 | 0 | 0 | 0 | For |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 283,956 | 0 | 0 | 0 | For |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 203,499 | 0 | 0 | 0 | For |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Claire Pomeroy”): 46,378,877 for, 383,528 withheld, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 91% for, 0.8% withheld (92% of the company cast a for/withheld vote).
The 114 asset managers below cast 100% of the shares they voted on this item FOR (30,904,031 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,202,371 | 0 | 0 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 380,101 | 0 | 0 | 0 | For |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 283,956 | 0 | 0 | 0 | For |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 203,499 | 0 | 0 | 0 | For |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Ellen M. Zane”): 39,666,573 for, 7,095,832 withheld, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 78% for, 14% withheld (92% of the company cast a for/withheld vote).
The 114 asset managers below cast 100% of the shares they voted on this item FOR (28,226,480 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,231,650 | 0 | 970,721 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 45,766 | 0 | 334,335 | 0 | Abstain |
| State Street | 0 | 0 | 355,759 | 0 | Abstain |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 292,855 | 0 | Abstain |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 283,956 | 0 | Abstain |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 68,199 | 0 | 135,300 | 0 | Abstain |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 42,123,209 for, 4,639,196 withheld, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 83% for, 9% withheld (92% of the company cast a for/withheld vote).
The 114 asset managers below cast 100% of the shares they voted on this item FOR (28,962,846 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,231,650 | 0 | 970,721 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 45,766 | 0 | 334,335 | 0 | Abstain |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 283,956 | 0 | Abstain |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 68,199 | 0 | 135,300 | 0 | Abstain |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Mark W. Kroll”): 46,097,712 for, 664,693 withheld, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 91% for, 1% withheld (92% of the company cast a for/withheld vote).
The 114 asset managers below cast 100% of the shares they voted on this item FOR (30,900,710 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,202,371 | 0 | 0 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 380,101 | 0 | 0 | 0 | For |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 283,956 | 0 | 0 | 0 | For |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 203,499 | 0 | 0 | 0 | For |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
99.2% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Michael J. Coyle”): 46,424,781 for, 337,624 withheld, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 92% for, 0.7% withheld (92% of the company cast a for/withheld vote).
The 114 asset managers below cast 100% of the shares they voted on this item FOR (30,908,346 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,202,371 | 0 | 0 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 380,101 | 0 | 0 | 0 | For |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 283,956 | 0 | 0 | 0 | For |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 203,499 | 0 | 0 | 0 | For |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Robert E. Abernathy”): 45,088,242 for, 1,674,163 withheld, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 89% for, 3% withheld (92% of the company cast a for/withheld vote).
The 114 asset managers below cast 100% of the shares they voted on this item FOR (30,574,892 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,202,371 | 0 | 0 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 380,101 | 0 | 0 | 0 | For |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 0 | 0 | 283,956 | 0 | Abstain |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 203,499 | 0 | 0 | 0 | For |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Proposal 5: The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:”): 47,679,417 for, 748,049 against, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 94% for, 1% against (96% of the company cast a for/against vote).
The 114 asset managers below cast 99.9% of the shares they voted on this item FOR (30,900,952 for, 8,015 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,202,371 | 0 | 0 | 0 | For |
| Capital Group | 4,082,955 | 0 | 0 | 0 | For |
| BlackRock | 3,506,360 | 0 | 0 | 0 | For |
| Fidelity | 2,614,428 | 0 | 0 | 0 | For |
| AMCAP FUND | 2,573,462 | 0 | 0 | 0 | For |
| Neuberger Berman | 2,238,280 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 937,264 | 0 | 0 | 0 | For |
| Royce | 823,657 | 0 | 0 | 0 | For |
| Invesco | 622,655 | 0 | 0 | 0 | For |
| Dimensional | 524,910 | 0 | 0 | 0 | For |
| Charles Schwab | 503,192 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 485,600 | 0 | 0 | 0 | For |
| T. Rowe Price | 385,042 | 0 | 0 | 0 | For |
| Hartford | 380,101 | 0 | 0 | 0 | For |
| State Street | 355,759 | 0 | 0 | 0 | For |
| Brighthouse | 293,035 | 0 | 15,929 | 0 | For |
| HEARTLAND GROUP INC | 295,000 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 292,855 | 0 | 0 | 0 | For |
| BOSTON TRUST WALDEN FUNDS | 283,956 | 0 | 0 | 0 | For |
| Equitable | 222,189 | 0 | 0 | 0 | For |
| John Hancock | 203,499 | 0 | 0 | 0 | For |
| Allspring | 200,275 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 200,110 | 0 | 0 | 0 | For |
| SCHWARTZ INVESTMENT TRUST | 159,000 | 0 | 0 | 0 | For |
| Victory Capital | 145,679 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Meeting held 2023-08-04.
100% fund support · no official result
The 12 asset managers below cast 100% of the shares they voted on this item FOR (127,390 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NORDEA INVESTMENT MANAGEMENT AB | 127,377 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 0 | 0 | 0 | One Year |
| Empower | 0 | 0 | 0 | 0 | One Year |
| Arjuna Capital | 0 | 0 | 0 | 0 | One Year |
| Triasima Portfolio Management inc. | 0 | 0 | 0 | 0 | One Year |
| Echo Street Capital Management LLC | 0 | 0 | 0 | 0 | One Year |
| TIMOTHY PLAN | 0 | 0 | 0 | 0 | 1 Year |
| APG Asset Management US Inc. | 0 | 0 | 0 | 0 | One Year |
| Desjardins Global Asset Management Inc. | 0 | 0 | 0 | 0 | One Year |
| CORNELL UNIVERSITY | 0 | 0 | 0 | 0 | One Year |
| Qtron Investments LLC | 0 | 0 | 0 | 0 | 1-Year |
| Coyle Financial Counsel LLC | 13 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Proposal 2: The shareholders approved, on an advisory basis, the compensation of the Company's named executive officers based upon the following votes:”): 46,230,466 for, 1,460,004 against, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 91% for, 3% against (94% of the company cast a for/against vote).
The 4 asset managers below cast 100% of the shares they voted on this item FOR (3,609 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Freedom Investment Management, Inc. | 106 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
| Argyle Capital Management Inc. | 70 | 0 | 0 | 0 | For |
Meeting held 2023-08-04.
98% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Proposal 4: The shareholders approved a proposal to adopt an amendment and restatement of the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan based upon the following votes:”): 45,678,506 for, 1,058,808 against, per its Form 8-K filed 2023-08-07 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 90% for, 2% against (92% of the company cast a for/against vote).
The 3 asset managers below cast 100% of the shares they voted on this item FOR (34,384 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 31,921 | 0 | 0 | 0 | For |
| TIMOTHY PLAN | 2,189 | 0 | 0 | 0 | For |
| CORNELL UNIVERSITY | 274 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
98% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Charles J. Dockendorff”): 46,789,643 for, 1,043,054 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 92% for, 2% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
99.4% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Christopher A. Simon”): 47,563,311 for, 269,386 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 94% for, 0.6% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
99.4% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Claire Pomeroy”): 47,553,094 for, 279,603 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 94% for, 0.6% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
99.5% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Diane M. Bryant”): 47,637,507 for, 195,190 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 94% for, 0.4% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
99% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Ellen M. Zane”): 47,122,780 for, 709,917 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 93% for, 1% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
99% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Lloyd E. Johnson”): 47,243,880 for, 588,817 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 93% for, 1% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
98% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Mark W. Kroll”): 46,938,807 for, 893,890 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 93% for, 2% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
99.2% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Michael J. Coyle”): 47,492,931 for, 339,766 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 94% for, 0.7% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
99% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Elect Director: Robert E. Abernathy”): 47,233,098 for, 599,599 withheld, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 93% for, 1% withheld (94% of the company cast a for/withheld vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Meeting held 2024-07-25 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).
98% Majority: yes · of votes cast
HAEMONETICS CORP.’s own tally for this item (“Proposal 3: The shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending March 30, 2024 based upon the following votes:”): 47,738,769 for, 1,049,682 against, per its Form 8-K filed 2024-07-25 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,705,779 outstanding shares: 94% for, 2% against (96% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (3,433 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ETF Series Solutions | 3,331 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 102 | 0 | 0 | 0 | For |
Ranked by the number of HAEMONETICS CORP. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 50,705,779 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Research Global Investors | 13.19% |
| 2 | Vanguard | 12.51% |
| 3 | Neuberger Berman | 11.32% |
| 4 | BlackRock | 10.25% |
| 5 | Fidelity | 8.87% |
| 6 | Capital Group | 8.05% |
| 7 | Wellington | 5.63% |
| 8 | AMCAP FUND | 5.08% |
| 9 | State Street | 3.92% |
| 10 | FRANKLIN ADVISERS INC | 2.94% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Capital Research Global Investors | 12.87% | DEF14A |
| BlackRock | 11.87% | 13F |
| Vanguard Group | 9.53% | 13F |
| Wellington Management | 8.42% | 13F |
| Neuberger Berman Group LLC | 6.96% | DEF14A |
| State Street | 3.61% | 13F |
| Franklin Templeton | 2.75% | 13F |
| FMR (Fidelity) | 2.40% | 13F |
| Geode Capital | 2.22% | 13F |
| Dimensional Fund Advisors | 1.82% | 13F |
Percentages above are of 50,705,779 shares outstanding, as reported by HAEMONETICS CORP. on its Form 10-Q dated 2023-07-01 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from HAEMONETICS CORP.’s 10-Q dated 2023-07-01. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At HAEMONETICS CORP.'s shareholder meeting held 2023-08-04, in the 2023-2024 proxy season, 345 asset managers reported how they voted in their SEC Form N-PX filings, covering 5,607 separate fund positions. Their filings are grouped here into 25 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of our named executive officers. — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: HAEMONETICS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2023-08-07.
HAEMONETICS CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.